In this work, we first demonstrated the use of inhalable NPs incorporating siRNA to block IL-11 signaling in a preclinical model of pulmonary fibrosis and showed great therapeutic potential of this strategy for repairing injured lung tissues. This evidence concerns the gene IL11 and pulmonary fibrosis.